Skip to content
10-Q/A

Quarterly Report

NEXT-ChemX Corporation

0001641172-25-017123

← back to feed
Filed
Jun 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Jun 27, 2025 28.55M sh
Shares Diluted Q1 2024 · Mar 31, 2024 28.55M sh
Shares Diluted Q1 2024 · Mar 31, 2023 28.37M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$292.69K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$310.15K
Stockholders Equity restated Q1 2024 · Mar 31, 2024 −$1.64M
Stockholders Equity restated Q1 2024 · Dec 31, 2023 −$1.09M
Stockholders Equity Q1 2024 · Mar 31, 2023 $773.9K
Stockholders Equity Q1 2024 · Dec 31, 2022 $731.87K
Current Liabilities Q1 2024 · Mar 31, 2024 $4.16M
Current Liabilities Q1 2024 · Dec 31, 2023 $3.93M
Total Liabilities Q1 2024 · Mar 31, 2024 $4.53M
Total Liabilities Q1 2024 · Dec 31, 2023 $3.93M
Current Assets Q1 2024 · Mar 31, 2024 $216.83K
Current Assets Q1 2024 · Dec 31, 2023 $140.33K
Total Assets restated Q1 2024 · Mar 31, 2024 $2.88M
Total Assets restated Q1 2024 · Dec 31, 2023 $2.84M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.02
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.02
Eps Basic Q1 2024 · Mar 31, 2024 −$0.02
Eps Basic Q1 2024 · Mar 31, 2023 −$0.02
Net Income restated Q1 2024 · Mar 31, 2024 −$556.41K
Net Income Q1 2024 · Mar 31, 2023 −$457.97K
Operating Income restated Q1 2024 · Mar 31, 2024 −$519.58K
Operating Income Q1 2024 · Mar 31, 2023 −$436.65K